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Procedural Innovations
Introduction
Despite significant advances in the treatment of thoracic 
infections, pleural empyema remains a problem in mod-
ern thoracic surgery. If the patient is medically unstable, 
the evacuation of pus and debridement can be managed 
by open-window thoracostomy (OWT).1,2 Vacuum-
assisted closure (VAC) therapy supports the treatment of 
acute or chronic wound infections both in general and in 
thoracic surgery. These benefits include the removal of 
accumulating fluid, increased oxygen tension in the 
wound, increased blood flow, and increased granulation 
tissue proliferation. The combination of OWT and VAC 
therapy should be discussed as soon as possible, espe-
cially for complicated pleural empyema and in patients 
with an increased risk for impaired wound healing.3 The 
Mini-VAC procedure offers a minimally invasive 
approach with the abdication of an OWT.4
In cases of highly infected/bacterial colonised pleural 
empyemas, flushing by a chest tube or the OWT is often 
necessary. In this report, we demonstrate that the Mini-
VAC treatment concept can also be used for the intermit-
tent instillation of the pleural cavity through the VAC 
sponge (Mini-VAC-instill).
Technique
Under general anaesthesia, a 5- to 6-cm long incision 
centred over the area of the greatest pleural fluid collec-
tion was made (Figure 1A). The intercostal muscle was 
divided, and the empyemal cavity was opened. After the 
intercostal aspiration of all pus and necrotic debris, the 
cavity was flushed with a polyhexanide solution 
(Lavanid 0.02%, Serag-Wiessner KG, Naila, Germany). 
Then, the VAC sponge (Instill Dressings, KCI Medical, 
Wiesbaden, Germany; 400-600 µm) was introduced in 
the pleural cavity over a flexible polymer membrane 
(Alexis, Applied Medical, Rancho Santa Margarita, CA) 
retractor (technique described earlier4; Figure 1B and 
C). On the top of the VAC sponge, the VAC instill pad, 
including the tubing, was positioned (Figure 1D). The 
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Enthusiasm for minimally invasive thoracic surgery is increasing. Thoracoscopy plays a significant therapeutic role in 
the fibrinopurulent stage (stage II) of empyema, in which loculated fluid cannot often be adequately drained by chest 
tube alone. For some debilitated and septic patients, further procedures such as open-window thoracostomy (OWT) 
with daily wound care or vacuum-assisted closure (VAC) therapy are necessary. In the present article, we propose 
a new option of minimally invasive VAC therapy including a topical solution of the empyema without open-window 
thoracostomy (Mini-VAC-instill). Three patients who underwent surgery using this technique are also presented. The 
discussion is focused on the advantages and disadvantages of the approach.
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wound volume determines the amount of fluid instilled. 
The vacuum device coupled with automated, controlled 
antiseptic fluid delivery regulates the instilled fluid vol-
ume. The volume of the pleural space was tested and 
determined (approximately 150 mL). The level of suc-
tion was set to −100 mm Hg from the start. The flushing 
of the pleural cavity was performed with a predeter-
mined amount of 0.02% polyhexanide solution 
(Lavanid) in an automated topical solution delivery 
modus (30 minutes every 8 hours). The patients were 
treated in parallel with wide spectrum antibiotics. Based 
on the microbiological results, the spectrum was occa-
sionally modified. The Mini-VAC-instill system was 
changed every 3 to 4 days. Only a small amount of 
debridement was required at each sponge change. The 
remaining pleural space was, in all cases after the Mini-
VAC-instill therapy, very small and only filled with an 
aminoglycoside antibiotic gentamicin sponge (Genta-
Coll resorb, Resorba GmbH, Nürnberg, Germany).
Case Reports
The demographic, clinical, and treatment characteristics 
of the patients are given in Table 1.
Case 1
A 56-year-old man was diagnosed with pleural empyema 
after a third course of palliative chemotherapy for gastric 
cancer stage IV. The pleural space was highly colonized 
with Escherichia coli and Bacillus cereus. The decision 
for quick and complete eradication was made. Because of 
the poor general condition of the patient (Karnofsky 
index 50%), we rejected an extensive surgical procedure 
(decortication). Considering the high bacterial coloniza-
tion, the Mini-VAC-instill system was implemented. 
After eleven days of treatment, the pleural cavity was 
visually determined to be clean, and the patient had 2 
negative quantitative cultures. On the 12th postoperative 
Figure 1. Technique of Mini-VAC-instill procedure: 5-cm incision over the pleural empyema (A), introduction of VAC sponge 
over ALEXIS retractor (B, C), and VAC-instill pad (D). VAC, vacuum-assisted closure.
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day, the remaining pleural space was filled with a haemo-
styptic collagen sponge containing the aminoglycoside 
antibiotic gentamicin (Genta-Coll resorb). The wound 
was closed with single stitches and healed per primam. 
The chemotherapeutic treatment of the gastric tumor was 
continued after 2 weeks.
Case 2
A 75-year-old male patient with a Karnofsky index of 50% 
presented to our department with recurrent fever that 
reached as high as 38°C and chills that had lasted for 1 
month. He also reported cough, dyspnea, and expectora-
tion. He was an active smoker with a 40-pack-year history 
of smoking. Routine laboratory testing showed inflamma-
tion. The chest X-ray showed a pleural effusion, and the 
chest computed tomography (CT) raised the suspicion of 
pleural empyema stage II. The patient underwent a tube 
thoracostomy. Escherichia coli and anaerobic species were 
isolated. The primary drainage treatment failed despite 
daily solution changes. The decision to use the Mini-VAC-
instill was made. The VAC sponge was changed only once. 
After 5 days of the Mini-VAC-instill treatment with 0.02% 
polyhexanide, the pleural cavity was sterile and could be 
primarily closed. The patient was discharged from the hos-
pital on the fifth postoperative day. At the 1-month follow-
up, no pleural empyema had recurred.
Case 3
A 87-year-old woman presented with left inspiratory chest 
pain in the emergency room. The medical history revealed 
a left thoracotomy for a kyphoplasty of thoracic vertebra 
12 and decompression of the spinal canal three months ear-
lier. In the past 6 weeks, she suffered with a fever and sig-
nificant worsening. The physical examination demonstrated 
cachexia of the patient, and auscultation and percussion of 
the lungs revealed fluid in the left hemithorax. Her arterial 
oxygen saturation at rest while breathing room air was 
90%, and her C-reactive protein level was increased by 
more than 100-fold. The CT scan of the thorax showed a 
fracture of thoracic vertebra 8 and both an intraspinal and 
stage II pleural empyema (Figure 2A). Antibiotic therapy 
with piperacillin/sulbactam was started. The microbiologi-
cal diagnosis was Staphylococcus aureus. After a chest 
tube thoracostomy, thoracic vertebra 8 was dorsally stabi-
lized by the neurosurgeons. Pus was demonstrated in the 
chest tube and in the intraspinal region. The chest tube was 
flushed with betaisodona 10% thrice per day. Because this 
treatment failed clinically and on the CT scan control, the 
decision to use the Mini-VAC-Instill was made 14 days 
after the neurosurgical operation. The Mini-VAC-instill 
therapy was performed with 150 mL of 0.02% poly-
hexanide solution, and the VAC sponge was only changed 
once. The pleural cavity was sterile and could be primarily 
closed on the seventh day after the first installation of the 
Mini-VAC. She was discharged from the hospital 5 days 
after primary chest closure. After the follow-up at 1 month, 
no pleural empyema had recurred (Figure 2B).
Discussion
The VAC-instill therapy differs from the standard VAC 
treatment in that topical solutions are cyclically flushed 
into the foam dressing and held for a user-selected period 
before removal under negative pressure. Studies have 
reported on the effectiveness of VAC-instill in wounds 
with high levels of exudate and pus and in acute traumatic 
wounds or wounds acutely debrided due to infected soft 
tissue.5,6
The bacteriology of pleural empyemas is often poly-
microbial and mixed, containing multiple species of both 
Table 1. Demographic, Clinical, and Treatment Characteristics.
Characteristic Patient 1 Patient 2 Patient 3
Age (years)/gender 75/male 57/male 87/female
Karnofsky index 50 50 40
Multimorbiditya Yes No No
Immunosuppression No Yes (chemotherapy) No
Etiology Primary Primary Secondary
Empyema Stage II Stage II Stage II
Primary intervention Chest tube Chest tube Chest tube
Microbiology Escherichia coli Escherichia coli, Bacillus cereus Staphylococcus aureus
Mini-VAC-instill therapy (days) 5 12 10
VAC-changes 1 3 1
Microbiology after Mini-VAC-instill Sterile Sterile Sterile
Discharge after Mini-VAC-instill 5th day 4th day 7th day
aMore than or equal to 4 chronic diseases.
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aerobic and anaerobic bacteria, with the latter found in up 
to 75% of the cases.7 The diffusion of antibiotics into the 
pleural fluid is good, but certain agents may be inacti-
vated in the presence of pus, low pH, and beta-lactamase 
enzymes. In addition to a surgical intervention, flushing 
of the pleural cavity by a chest tube is often necessary to 
clean the empyemal cavity. If the patient is also medically 
unstable, the evacuation of pus and debridement can be 
managed traditionally by OWT and daily open wound 
treatment, including flushing of the pleural space.
The present Mini-VAC-instill therapy (an upgrade of 
Mini-VAC) guarantees the advantage of an open treat-
ment, including flushing without OWT. Rib resection for 
OWT is associated with more postoperative pain and a 
muscle flap closure in most cases.
The decision not to proceed with classical decortica-
tion of the lung appears not to be a disadvantage because 
similar lung reexpansion was achieved by debridement 
alone without decortication in patients presenting with 
empyema.8
The Mini-VAC-instill allows pleural cleaning, irriga-
tion and removal of infectious materials. Solutions 
intended for topical use include topical cleansers, antibi-
otics, antifungals, and antiseptics. Intervals in pleural 
flushing (the ebb-and-flow technique) are better than 
continuous pleural flushing with standard intervals.9 In 
practice, these cycles of flushing are repeated from 4 to 
12 times hourly.10,11 According to the present state of 
knowledge, polyhexanide is the first-choice antiseptic 
solution when using instillation for acutely or chronically 
infected wounds (after debridement).12 However, the key 
aspect of this therapy is the delivery method of the topical 
solution, not the type of solution.
The system should only be exchanged every 3 to 4 
days. Thus, daily time-consuming doctor and caregiver 
wound intervention is not necessary. The sponge changes 
are facile and fast because the Mini-Vac-instill therapy 
also enables minimization of intraoperative manual activ-
ities (eg, debridement) by fast cleaning.
The wound should be assessed at every dressing change, 
and the decision to continue the Mini-VAC-instill should be 
made during this time. We recommend Mini-VAC-instill 
therapy only for hospital use because patients are often sep-
tic and infected by multiple species of bacteria. After clean-
ing of the pleural space, conversion to simple Mini-VAC 
therapy to bridge to the ambulant sector, with the aim of 
further reduction of the pleural cavity, is possible.
Conclusions
Standard pleural VAC therapy offers rapid treatment for 
complex pleural empyema. In septic patients with highly 
infected/bacterially colonized pleural empyema, we rec-
ommend Mini-VAC-instill therapy. This procedure pro-
vides intermittent topical solution delivery and removal 
from the wound site. Wound cleaning, the removal of 
infectious material and wound healing are supported by 
this system. The procedure is minimally invasive and 
highly compatible, especially in patients in poor general 
condition.
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